Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J DeGraff

Showing results (21-30 of 66) with videos related to

Pageof 7
Sort By:
Plos One|April 12, 2013
Activation of NF-kappa B signaling promotes growth of prostate cancer cells in boneRenjie Jin, Julie A Sterling, James R Edwards, et al.
Cancer Metastasis Reviews|January 24, 2014
Mouse models of prostate cancer: picking the best model for the questionMagdalena M Grabowska, David J DeGraff, Xiuping Yu, et al.
The Journal of Pathology. Clinical Research|February 12, 2026
Expression of Nectin-4 and Trop-2 in upper tract urothelial carcinoma: implications for biomarker-driven antibody-drug conjugate therapyPing Shi, Qingqing Wu, Yong Zhang, et al.
Cells|November 27, 2021
Intratumoral Heterogeneity Promotes Collective Cancer Invasion through NOTCH1 VariationPeter Torab, Yue Yan, Mona Ahmed, et al.
Scientific Reports|January 24, 2019
Maintenance of the bladder cancer precursor urothelial hyperplasia requires FOXA1 and persistent expression of oncogenic HRASChristopher H Yee, Zongyu Zheng, Lauren Shuman, et al.
Scientific Reports|January 31, 2020
Evaluation of PD-L1 and other immune markers in bladder urothelial carcinoma stratified by histologic variants and molecular subtypesHuili Li, Qingzhao Zhang, Lauren Shuman, et al.
European Urology|September 30, 2018
Intratumoral Heterogeneity of Bladder Cancer by Molecular Subtypes and Histologic VariantsJoshua I Warrick, Gottfrid Sjödahl, Matthew Kaag, et al.
Molecular Cancer Research : MCR|March 20, 2014
Tailoring peptidomimetics for targeting protein-protein interactionsOmar N Akram, David J DeGraff, Jonathan H Sheehan, et al.
Carcinogenesis|July 5, 2013
Macrophage migratory inhibitory factor promotes bladder cancer progression via increasing proliferation and angiogenesisShilpa Choudhary, Poornima Hegde, James R Pruitt, et al.
Journal of Cellular Physiology|May 12, 2007
Hormonal regulation of IGFBP-2 proteolysis is attenuated with progression to androgen insensitivity in the LNCaP progression modelDavid J Degraff, Manisha Malik, Qian Chen, et al.
Pageof 7

Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
Plos One|April 12, 2013
Activation of NF-kappa B signaling promotes growth of prostate cancer cells in boneRenjie Jin, Julie A Sterling, James R Edwards, et al.
Cancer Metastasis Reviews|January 24, 2014
Mouse models of prostate cancer: picking the best model for the questionMagdalena M Grabowska, David J DeGraff, Xiuping Yu, et al.
The Journal of Pathology. Clinical Research|February 12, 2026
Expression of Nectin-4 and Trop-2 in upper tract urothelial carcinoma: implications for biomarker-driven antibody-drug conjugate therapyPing Shi, Qingqing Wu, Yong Zhang, et al.
Cells|November 27, 2021
Intratumoral Heterogeneity Promotes Collective Cancer Invasion through NOTCH1 VariationPeter Torab, Yue Yan, Mona Ahmed, et al.
Scientific Reports|January 24, 2019
Maintenance of the bladder cancer precursor urothelial hyperplasia requires FOXA1 and persistent expression of oncogenic HRASChristopher H Yee, Zongyu Zheng, Lauren Shuman, et al.
Scientific Reports|January 31, 2020
Evaluation of PD-L1 and other immune markers in bladder urothelial carcinoma stratified by histologic variants and molecular subtypesHuili Li, Qingzhao Zhang, Lauren Shuman, et al.
European Urology|September 30, 2018
Intratumoral Heterogeneity of Bladder Cancer by Molecular Subtypes and Histologic VariantsJoshua I Warrick, Gottfrid Sjödahl, Matthew Kaag, et al.
Molecular Cancer Research : MCR|March 20, 2014
Tailoring peptidomimetics for targeting protein-protein interactionsOmar N Akram, David J DeGraff, Jonathan H Sheehan, et al.
Carcinogenesis|July 5, 2013
Macrophage migratory inhibitory factor promotes bladder cancer progression via increasing proliferation and angiogenesisShilpa Choudhary, Poornima Hegde, James R Pruitt, et al.
Journal of Cellular Physiology|May 12, 2007
Hormonal regulation of IGFBP-2 proteolysis is attenuated with progression to androgen insensitivity in the LNCaP progression modelDavid J Degraff, Manisha Malik, Qian Chen, et al.
Pageof 7